Eventide Asset Management - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 161 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$2,721,000
-49.1%
482,5000.0%0.16%
-45.5%
Q2 2015$5,351,000
-29.3%
482,5000.0%0.29%
-49.0%
Q1 2015$7,566,000
+3.1%
482,5000.0%0.57%
-29.0%
Q4 2014$7,339,000
+41.0%
482,5000.0%0.80%
+10.2%
Q3 2014$5,204,000
-29.4%
482,5000.0%0.73%
-27.4%
Q2 2014$7,368,000
-11.9%
482,500
+4.3%
1.00%
-22.8%
Q1 2014$8,362,000
+177.1%
462,500
+112.8%
1.30%
+39.6%
Q4 2013$3,018,000217,3000.93%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders